Investor Ab

Institutional investor · Portfolio as of Q1 2023

Q1 2023 Summary

Opened 2 positions, added to 1. Portfolio: $3.2B across 7 positions.

Top Holdings7 positions

Checking export access…
Activity:
NDAQ

Nasdaq, Inc.

58.2M$3.2B99.9%$32.48+60.28%
14 qtrssince 2019-Q4
Unchanged
0
TIGO

Millicom International Cellular S.A.

50,000$944,0000.0%$15.710.00%
1 qtr
New
38
MU

Micron Technology, Inc.

13,250$799,3730.0%$53.04+12.05%
3 qtrssince 2022-Q3
Increased
39
SWK

Stanley Black & Decker, Inc.

5,700$459,1350.0%$108.58-35.46%
7 qtrssince 2021-Q3
Unchanged
0
NEON

Neonode Inc.

3,774$302,6800.0%$7.610.00%
1 qtr
New
35
WE
WEDelisted

WEWORK INC

227,139$177,1680.0%——
6 qtrssince 2021-Q4
Unchanged
0
AGRX
AGRXDelisted

AGILE THERAPEUTICS INC

87,754$19,6570.0%——
4 qtrssince 2022-Q2
Unchanged
0
$3.2B
AUM
7
Positions
Q1 2023
Filing
HI rating · 1.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2021-Q4$4,079,425,0008.843906777%
2022-Q1$3,461,834,000-15.1391678974%
2022-Q2$2,960,410,000-14.484345581%
2022-Q3$3,302,342,00011.5501569039%
2022-Q4$3,570,677,3468.12560740226%
2023-Q1$3,183,535,242-10.8422595067%
Activity profile
$ moved · Q1'23
New76%Increased24%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.5 years
<1Q29%1-4Q0%1-2Y29%2Y+43%

Investor Ab manages $3.2B across 7 positions as of Q1 2023. Top holdings: NDAQ (99.9%), TIGO (0.0%), MU (0.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1/5.0.

Top holdings by portfolio weight

Total AUM$3B
NDAQ99.92%
TIGO0.03%
MU0.03%
SWK0.01%
NEON0.01%
WE0.01%
AGRX0.00%

Portfolio allocation by GICS sector

Sectors5
Financial Services99.92%
Technology0.03%
Communication Services0.03%
Industrials0.01%
Unknown0.01%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L33
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used